Sf. Sanchez et al., FASTING-INDUCED CHANGES TO THE PHARMACOKINETIC BEHAVIOR OF ALBENDAZOLE AND ITS METABOLITES IN CALVES, Journal of veterinary pharmacology and therapeutics, 20(1), 1997, pp. 38-47
The influence of fasting on the bioavailability and disposition kineti
cs of albendazole (ABZ) and its metabolites in cattle was investigated
. ABZ (10 mg/kg) was given by intraruminal (i.r.) (Experiment 1) and i
ntravenous (i.v.) (Experiment 2) administration to Holstein calves eit
her fed ad libitum (control) or subjected to a 48 h fasting period (fa
sted group) prior to treatment. The rate of passage of digesta through
the gastrointestinal (GI) tract was evaluated by measurement of cobal
t faecal excretion following the oral administration of the sodium-cob
alt-ethylendiamine-tetracetic acid complex to calves subjected to the
feeding conditions above described, Jugular blood and abomasal fluid (
via cannula) samples were collected over 120 h post-treatment; samples
were analysed by high performance liquid chromatography (HPLC) for AB
Z, ABZ sulphoxide (ABZSO) and ABZ sulphone (ABZSO(2)). Fasting the ani
mals prior to the i.r. treatment resulted in pronounced modifications
to the plasma and abomasal fluid disposition kinetics of ABZ and its m
etabolites. A greater extent of GI absorption with significantly highe
r C-max (150%) and AUC (310%) values for ABZSO in plasma, was observed
in fasted compared to fed animals following the i.r. administration o
f ABZ. Extended detection of ABZ metabolites resulting in significantl
y longer plasma t(1/2el) and MRT was also obtained in fasted compared
to fed calves. These results correlated with the substantially enhance
d availability of ABZ and its metabolites (AUCs over 200% greater) in
the abomasal fluid of the fasted animals. Fasting did not induce chang
es to the plasma disposition of either ABZ or its metabolites after th
e i.v. treatment. The digesta passage rate, measured by the amount of
cobalt excreted in faeces, was significantly lower in fasted compared
to animals fed ad libitum. A delayed GI transit time that decreases th
e rate of passage of the drug down the digestive tract, may have accou
nted for enhanced ABZ dissolution and absorption in fasted compared to
fed calves. The findings reported in this article show that fasting p
rior to treatment notably affects the bioavailability and disposition
kinetics of ABZ and its metabolites in cattle.